CVS Group (LON:CVSG)‘s stock had its “buy” rating restated by equities researchers at Peel Hunt in a report issued on Friday, February 16th. They presently have a GBX 1,350 ($18.65) target price on the stock. Peel Hunt’s target price would indicate a potential upside of 26.88% from the company’s previous close.

Separately, Berenberg Bank reissued a “buy” rating and issued a GBX 1,450 ($20.03) price target on shares of CVS Group in a report on Thursday, November 30th.

Shares of CVS Group (LON:CVSG) traded down GBX 8 ($0.11) during mid-day trading on Friday, reaching GBX 1,064 ($14.70). The company had a trading volume of 76,777 shares, compared to its average volume of 246,421. The firm has a market capitalization of $756.49 and a PE ratio of 6,650.00. CVS Group has a 52-week low of GBX 13.22 ($0.18) and a 52-week high of GBX 1,500 ($20.72).

COPYRIGHT VIOLATION NOTICE: “CVS Group (LON:CVSG) Stock Rating Reaffirmed by Peel Hunt” was posted by Marea Informative and is the property of of Marea Informative. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The original version of this news story can be accessed at

CVS Group Company Profile

CVS Group plc is a holding company. The principal activities of the Company are to operate animal veterinary practices, veterinary diagnostic businesses, pet crematoria and an online pharmacy and retail business. Its segments are Veterinary Practice, Laboratories, Pet Crematoria and Animed Direct. The Veterinary Practice segment offers treatment for companion animals, equine and farm animals.

Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with's FREE daily email newsletter.